Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
News|Articles|May 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-04-2014
- Volume 10
- Issue 6
EquipNet Celebrates 15 Years of Asset Management
Author(s)Pharmaceutical Technology Editors
EquipNet announced its 15th year of supplying asset management services.
Advertisement
EquipNet employees more than 130 people in locations throughout North America, Latin America, Europe, and Asia. EquipNet has provided asset management programs to numerous companies including, Merck, GE Healthcare, Johnson & Johnson, Novartis, Cargill, Mars/Wrigley, Unilever, and Colgate-Palmolive.
Source:
Articles in this issue
over 12 years ago
India Offers Biopharma Opportunities and Challengesover 12 years ago
Are CMOs Out of Synch With Market Realities?over 12 years ago
Key Considerations for Quality-Technical Agreementsover 12 years ago
Defining Quality Metrics to Ease Drug Shortagesover 12 years ago
Cocrystals: Industry Takes a Wait-and-See Approachover 12 years ago
DCAT Sharp Sourcing Addresses Procurement Topicsover 12 years ago
FDA Expands CERSI Networkover 12 years ago
HPAPIs: Fast-growing Segment Presents Challenges and Opportunitiesover 12 years ago
Turkish Pharma Manufacturers Look to New Marketsover 12 years ago
Lilly Oncology On Canvas Celebrates 10 Years of Cancer JourneysAdvertisement
Related to this article
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.
Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Ask the Expert: Choosing Ingredient Suppliers
3
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5